{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:12:50Z","timestamp":1778850770494,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.resinv.2026.101425","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T14:42:25Z","timestamp":1776177745000},"page":"101425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The therapeutic dilemma triangle in rheumatoid arthritis-related respiratory disease"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2480-6087","authenticated-orcid":false,"given":"Hideaki","family":"Yamakawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2026.101425_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3899\/jrheum.2023-0334","article-title":"Rheumatoid arthritis: the continuum of disease and strategies for prediction, early intervention, and prevention","volume":"51","author":"O'Neil","year":"2024","journal-title":"J Rheumatol"},{"key":"10.1016\/j.resinv.2026.101425_bib2","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.3390\/jcm10173806","article-title":"Decision-making strategy for the treatment of rheumatoid arthritis-associated interstitial lung disease (RA-ILD)","volume":"10","author":"Yamakawa","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.resinv.2026.101425_bib3","article-title":"The prevalence of interstitial lung disease and bronchiectasis in rheumatoid arthritis: a systematic review and meta-analysis","volume":"42","author":"Baekdal","year":"2025","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.resinv.2026.101425_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1513\/AnnalsATS.202107-876CME","article-title":"Airway disease in rheumatoid arthritis","volume":"19","author":"Matson","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resinv.2026.101425_bib5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/hon.2525","article-title":"Rheumatoid arthritis and lymphoma: incidence, pathogenesis, biology, and outcome","volume":"36","author":"Klein","year":"2018","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.resinv.2026.101425_bib6","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/art.43105","article-title":"Immune aging in rheumatoid arthritis","volume":"77","author":"Weyand","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.resinv.2026.101425_bib7","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.3390\/jcm10163552","article-title":"Infectious pneumonia and lower airway microorganisms in patients with rheumatoid arthritis","volume":"10","author":"Ideguchi","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.resinv.2026.101425_bib8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/03009741003604542","article-title":"Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA","volume":"39","author":"Nakajima","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.resinv.2026.101425_bib9","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/ard-2022-223335","article-title":"2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases","volume":"82","author":"Fragoulis","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2026.101425_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European respiratory society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101425_bib11","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2026.101425_bib12","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","article-title":"Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort","volume":"49","author":"Koduri","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2026.101425_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1542400","article-title":"Navigating interstitial lung disease associated with rheumatoid arthritis (RA-ILD): from genetics to clinical landscape","volume":"12","author":"Bernardinello","year":"2025","journal-title":"Front Med"},{"issue":"Suppl 1","key":"10.1016\/j.resinv.2026.101425_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","article-title":"British thoracic society guideline for bronchiectasis in adults","volume":"74","author":"Hill","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2026.101425_bib15","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1513\/AnnalsATS.201506-333OC","article-title":"A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis","volume":"12","author":"Finch","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resinv.2026.101425_bib16","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.chest.2016.12.024","article-title":"Bronchiectasis rheumatoid overlap syndrome is an independent risk factor for mortality in patients with bronchiectasis: a multicenter cohort study","volume":"151","author":"De Soyza","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101425_bib17","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","article-title":"Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101425_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106125","article-title":"The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue disease","volume":"172","author":"Yamakawa","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2026.101425_bib19","series-title":"Lung disease associated with rheumatoid arthritis","first-page":"59","article-title":"Therapeutic strategy for airway disease in rheumatoid arthritis","author":"Tokuda","year":"2018"},{"issue":"21","key":"10.1016\/j.resinv.2026.101425_bib20","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.2169\/internalmedicine.5214-24","article-title":"Rheumatoid Arthritis-UIP mainly caused by an airway-disorder: truly honeycombing?","volume":"64","author":"Yamakawa","year":"2025","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2026.101425_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00408-015-9828-1","article-title":"Visual assessment of chest computed tomography findings in anti-cyclic citrullinated peptide antibody positive rheumatoid arthritis: is it associated with airway abnormalities?","volume":"194","author":"Park","year":"2016","journal-title":"Lung"},{"key":"10.1016\/j.resinv.2026.101425_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02533-2024","article-title":"ERS\/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease","volume":"67","author":"Antoniou","year":"2026","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101425_bib23","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/mr\/roac117","article-title":"Clinical characteristics of rheumatoid arthritis patients complicated with pulmonary nontuberculous mycobacterial disease: a cross-sectional case series study","volume":"33","author":"Nakayama","year":"2023","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.resinv.2026.101425_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/acr.23426","article-title":"Impact of sustained remission on the risk of serious infection in patients with rheumatoid arthritis","volume":"70","author":"Accortt","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.resinv.2026.101425_bib25","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1038\/s41598-022-07968-w","article-title":"TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic area","volume":"12","author":"Park","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2026.101425_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101425_bib27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2026.101425_bib28","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/annrheumdis-2013-204960","article-title":"Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?","volume":"74","author":"Arkema","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2026.101425_bib29","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor \u03b1\u2013neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101425_bib30","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","article-title":"Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British society for rheumatology biologics register (BSRBR)","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2026.101425_bib31","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1038\/emi.2016.10","article-title":"Updates on the risk factors for latent tuberculosis reactivation and their managements","volume":"5","author":"Ai","year":"2016","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.resinv.2026.101425_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.resinv.2017.01.002","article-title":"Consensus statements for medical practice: Biological agents and lung disease [Abridged English translation by the Japanese Respiratory Society]","volume":"55","author":"Tokuda","year":"2017","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2026.101425_bib33","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/mr\/roab032","article-title":"Rheumatoid arthritis with nontuberculous mycobacterial pulmonary disease: a retrospective, single-centre cohort study","volume":"32","author":"Takei","year":"2022","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.resinv.2026.101425_bib34","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00803-2024","article-title":"Fungal lung disease","volume":"64","author":"Jaggi","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101425_bib35","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.resinv.2026.101425_bib36","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/cid\/ciaa1855","article-title":"Guidance on imaging for invasive pulmonary aspergillosis and mucormycosis: from the imaging working group for the revision and update of the consensus definitions of fungal disease from the EORTC\/MSGERC","volume":"72","author":"Alexander","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2026.101425_bib37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3201\/eid1903.121151","article-title":"Increasing pneumocystis pneumonia, England, UK, 2000\u20132010","volume":"19","author":"Maini","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resinv.2026.101425_bib38","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/rheumatology\/keab647","article-title":"Prophylaxis against pneumocystis pneumonia in rheumatoid arthritis patients treated with b\/tsDMARDs: insights from 3787 cases in the FIRST registry","volume":"61","author":"Sonomoto","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2026.101425_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/RHU.0000000000000731","article-title":"Risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis and a prophylactic indication of trimethoprim\/sulfamethoxazole","volume":"24","author":"Yukawa","year":"2018","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.resinv.2026.101425_bib40","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/mr\/roac088","article-title":"Outcomes and risk factors for mortality in pneumocystis pneumonia patients with rheumatoid arthritis: a multicentre retrospective cohort study","volume":"33","author":"Mori","year":"2023","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.resinv.2026.101425_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214324","article-title":"Prognostic factors of pneumocystis pneumonia in patients with systemic autoimmune diseases","volume":"14","author":"Kageyama","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2026.101425_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-25451-4","article-title":"Risk factors associated with cytomegalovirus reactivation in patients receiving immunosuppressive therapy for rheumatic diseases: a retrospective study","volume":"12","author":"Shimada","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2026.101425_bib43","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2214\/ajr.181.4.1811059","article-title":"Thin-section CT findings in 32 immunocompromised patients with cytomegalovirus pneumonia who do not have AIDS","volume":"181","author":"Franquet","year":"2003","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.resinv.2026.101425_bib44","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jtct.2021.05.001","article-title":"American society for transplantation and cellular therapy series: #3-prevention of cytomegalovirus infection and disease after hematopoietic cell transplantation","volume":"27","author":"Hakki","year":"2021","journal-title":"Transplant Cell Ther"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526000596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526000596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:58:46Z","timestamp":1778849926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534526000596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2212534526000596"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101425","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic dilemma triangle in rheumatoid arthritis-related respiratory disease","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101425"}}